在心力衰竭中管理肥胖:一个倾斜天平的机会?
Josephine Harrington1, G Michael Felker1, Ildiko Lingvay2
1Division of Cardiology, Department of Internal Medicine, Duke University Medical Center, Durham, North Carolina, USA; Duke Clinical Research Institute, Durham, North Carolina, USA.
JACC. Heart failure
|October 28, 2023
概括
肥胖增加了心力衰竭 (HF) 的风险,并使结果变得更糟. 减肥干预措施可以改善HF症状,并减少患有心力衰竭的肥胖患者住院治疗.
科学领域:
- 心脏病学 心脏病学
- 肥胖医学 肥胖医学
- 临床研究 临床研究
背景情况:
- 肥胖是发展心力衰竭 (HF) 的重要危险因素.
- 患有HF和肥胖症的患者经历了更大的症状负担,减少了炼能力,以及更多的HF住院.
- 体重减轻对肥胖个体HF结果的影响尚不清楚.
研究的目的:
- 调查肥胖和心力衰竭 (HF) 结果之间的关联.
- 探索减肥对肥胖患者HF结局的影响.
- 了解新型减肥疗法在肥胖人群中治疗高血压的作用.
主要方法:
- 对肥胖和HF结局现有证据的审查.
- 从正在进行的和已结束的心血管结局试验中分析数据.
- 专注于心力衰竭和保存喷射分数 (HFpEF) 的患者.
主要成果:
- 肥胖与较差的HF结果有关,包括较高的症状负担和住院率.
- 体重减轻对肥胖HF患者这些特定结果的影响需要进一步澄清.
- 新的医学疗法能够显著减肥,这可能会影响HF管理.
结论:
- 需要进一步的研究来澄清体重减轻对肥胖的HF患者的好处.
- 新型减肥疗法可能为改善HF结果和减少症状负担提供新的途径.
- 鉴于肥胖和高血压的患病率不断上升,了解这些关联至关重要.
相关概念视频
Heart Failure VI: Adjunct Therapies
15
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
15
Heart Failure V: Medical Management
9
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
9
Heart Failure VII: Nursing Interventions
85
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
85
Cardiomyopathy VI: Nursing Management
13
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
13
Cardiomyopathy V: Interprofessional Care
14
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
14
Mitral Regurgitation IV: Nursing Management
40
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
40


